Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Ting

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|August 1, 2018
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Blood Cancer Journal|March 2, 2019
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
The Journal of Cell Biology|September 16, 2015
Asymmetric cell division during T cell development controls downstream fateKim Pham, Raz Shimoni, Mirren Charnley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2020
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive ChemotherapyChong Chyn Chua, Andrew W Roberts, John Reynolds, et al.
Developmental Cell|July 21, 2010
Epidermal wound repair is regulated by the planar cell polarity signaling pathwayJacinta Caddy, Tomasz Wilanowski, Charbel Darido, et al.
Nature Communications|September 1, 2018
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cellsCedric S Tremblay, Jesslyn Saw, Sung Kai Chiu, et al.
Best Practice & Research. Clinical Haematology|December 13, 2023
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes RegistryLucy C Fox, Zoe K McQuilten, Frank Firkin, et al.
Blood Cancer Journal|October 2, 2021
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood Advances|February 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood Advances|November 21, 2025
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|August 1, 2018
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Blood Cancer Journal|March 2, 2019
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
The Journal of Cell Biology|September 16, 2015
Asymmetric cell division during T cell development controls downstream fateKim Pham, Raz Shimoni, Mirren Charnley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2020
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive ChemotherapyChong Chyn Chua, Andrew W Roberts, John Reynolds, et al.
Developmental Cell|July 21, 2010
Epidermal wound repair is regulated by the planar cell polarity signaling pathwayJacinta Caddy, Tomasz Wilanowski, Charbel Darido, et al.
Nature Communications|September 1, 2018
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cellsCedric S Tremblay, Jesslyn Saw, Sung Kai Chiu, et al.
Best Practice & Research. Clinical Haematology|December 13, 2023
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes RegistryLucy C Fox, Zoe K McQuilten, Frank Firkin, et al.
Blood Cancer Journal|October 2, 2021
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood Advances|February 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood Advances|November 21, 2025
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Pageof 5